2-amino-5-phosphonovalerate has been researched along with Alveolar Bone Atrophy in 1 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gray, C | 1 |
| Marie, H | 1 |
| Arora, M | 1 |
| Tanaka, K | 1 |
| Boyde, A | 1 |
| Jones, S | 1 |
| Attwell, D | 1 |
1 other study available for 2-amino-5-phosphonovalerate and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Glutamate does not play a major role in controlling bone growth.
Topics: 2-Amino-5-phosphonovalerate; Alveolar Bone Loss; Amino Acid Transport System X-AG; Animals; Animals, | 2001 |